Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. (Q43827112)

27 November 2017

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. (English)

1 reference

27 November 2017

1 reference

3

1 reference

27 November 2017

Berding G

1

1 reference

27 November 2017

Odin P

2

1 reference

27 November 2017

Nikkhah G

4

1 reference

27 November 2017

Matthies C

5

1 reference

27 November 2017

Peschel T

6

1 reference

27 November 2017

Shing M

7

1 reference

27 November 2017

Kolbe H

8

1 reference

27 November 2017

van Den Hoff J

9

1 reference

27 November 2017

Fricke H

10

1 reference

27 November 2017

Dengler R

11

1 reference

27 November 2017

Samii M

12

1 reference

27 November 2017

Knapp WH

13

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

16

1 reference

27 November 2017

6

1 reference

27 November 2017

1014-1022

1 reference

Parkinson's disease. First of two parts

27 November 2017

1 reference

Parkinson's disease. Second of two parts

21 January 2018

1 reference

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.

21 January 2018

1 reference

Cortical glucose metabolism in Parkinson's and Alzheimer's disease

21 January 2018

1 reference

A clinicopathologic study of 100 cases of Parkinson's disease

21 January 2018

1 reference

Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.

21 January 2018

1 reference

Cortical glucose metabolism in Parkinson's disease without dementia

21 January 2018

1 reference

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

Parieto-occipital glucose hypometabolism in Parkinson's disease with autonomic failure.

21 January 2018

1 reference

Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.

21 January 2018

1 reference

Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease

21 January 2018

1 reference

The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.

21 January 2018

1 reference

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

21 January 2018

1 reference

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

21 January 2018

1 reference

High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.

21 January 2018

1 reference

Apomorphine induced cognitive changes in Parkinson's disease

21 January 2018

1 reference

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

21 January 2018

1 reference

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

On the construction of functional maps in positron emission tomography.

21 January 2018

1 reference

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.

21 January 2018

1 reference

Memory and skill acquisition in Parkinson's disease and frontal lobe dysfunction

21 January 2018

1 reference

Fronto-striatal cognitive deficits at different stages of Parkinson's disease

21 January 2018

1 reference

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

21 January 2018

1 reference

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

21 January 2018

1 reference

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

21 January 2018

1 reference

Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients

21 January 2018

1 reference

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

21 January 2018

1 reference

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

Dissociation in prefrontal cortex of affective and attentional shifts

21 January 2018

1 reference

Specific cognitive deficits in mild frontal variant frontotemporal dementia

21 January 2018

1 reference

Bilateral frontal cortical contusion in rats: behavioral and anatomic consequences

21 January 2018

1 reference

Disorders of higher mental function due to single infarctions in the thalamus and in the area of the thalamofrontal tracts.

21 January 2018

1 reference

Neuropsychological correlates of a right unilateral lacunar thalamic infarction

21 January 2018

1 reference

Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals

21 January 2018

1 reference

The metabolic topography of parkinsonism

21 January 2018

1 reference

Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.1212

1 reference

27 November 2017

1 reference